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introduction: This study aimed to assess psychological distress (PD) as scored by the 
Distress Thermometer (DT) in adult primary brain tumor patients and caregivers (CGs) in 
a clinic setting and ascertain if any high-risk subgroups for PD exist.
Material and methods: From May 2012 to August 2013, n = 96 patients and n = 32 
CG underwent DT screening at diagnosis, and a differing cohort of n = 12 patients and 
n = 14 CGs at first recurrence. Groups were described by diagnosis (high grade, low
grade, and benign) and English versus non English speaking. Those with DT score ≥4 
met caseness criteria for referral to psycho-oncology services. One-way ANOVA tests
were conducted to test for between-group differences where appropriate.
results: At diagnosis and first recurrence, 37.5 and 75.0% (respectively) of patients
had DT scores above the cutoff for distress. At diagnosis, 78.1% of CGs met caseness 
criteria for distress. All CGs at recurrence met distress criterion. Patients with high-grade 
glioma had significantly higher scores than those with a benign tumor. For patients at
diagnosis, non English speaking participants did not report significantly higher DT scores 
than English speaking participants.
Discussion: Psychological distress is particularly elevated in CGs and in patients with
high-grade glioma at diagnosis. Effective PD screening, triage, and referral by skilled
care coordinators are vital to enable timely needs assessment, psychological support,
and effective intervention.
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introduction
Patients with primary brain tumors (PBT) experience a myriad 
of complex physical, emotional, cognitive needs (1, 2), which 
can have adverse psychological effects on both the patient and 
their caregivers. In particular, patients diagnosed with high-
grade glioma (HGG) have a poor prognosis and limited life 
expectancy and as such often experience rapid decline in physical 
and cognitive functioning (3). They can often exhibit a dynamic 
constellation of needs throughout the care trajectory, from initial 
diagnosis to tumor recurrence through to the palliative phase (4, 
5), with profound changes not only in physical functioning but 
also in psychological distress (6), mood, cognition, and behavior.
Due to the high emotional sequelae of having a PBT (7), it is 
important that patients are routinely screened for psychological 
distress and have effective and timely interventions instituted. 
The National Comprehensive Cancer Network (NCCN) Distress 
Thermometer (DT) is one of the most familiar and widely adopted 
psychological distress screening tools utilized in oncology 
populations (8, 9). Several studies have described DT screening in 
malignant and benign PBT cohorts, with the majority undertak-
ing assessments relatively soon after initial diagnosis. Keir et al. 
(10) assessed a convenience sample of malignant PBT patients 
with time interval from tumor diagnosis to testing varying from 
10 days to 22 years, with a median time of 1.8 years. Using a cutoff 
score of DT ≥4, 52% of their cohort were classified as suffering 
from elevated psychological distress. Similarly, Kvale et al. (11) 
applied the DT in a sample of 50 glioblastoma patients, with 22% 
of patients seen within the first 4 months after diagnosis. They 
reported a mean distress score of 2.15 (SD = 2.66), with caseness 
criteria using a DT score of ≥4 met by 28%.
Only a few studies have published serial or longitudinal DT 
data in PBT populations; however, assessment was acquired at 
pre-defined chronological time points such as baseline, and six 
monthly (12), or after a short interval such as pre- and post-
radiotherapy (13). These time points did not specifically reflect 
the actual treatment phase or disease status such as at tumor 
recurrence (14) or the terminal phase when distress is known 
to be elevated (4, 15). Keir et al. (6) categorized 83 glioblastoma 
patients into those who had been diagnosed either less than or 
greater than 18 months. They reported that 59% of long-term sur-
vivors (LTS) met the DT ≥4 cutoff score for distress (M = 4.61, 
SD = 3.12) compared with 49% of those diagnosed <18 months.
It is widely acknowledged that the impact and burden on 
caregivers of brain tumor patients is significant (3, 16–19). 
Caregivers can experience a range of unmet supportive care needs 
and remain at risk of physical, emotional, and financial stressors 
themselves (2, 20–22). Despite this, there is currently only sparse 
literature documenting both patient and caregiver psychological 
distress levels.
It is notable that even in subgroups of PBT survivors with more 
favorable outcomes such as pituitary tumors (23) or low-grade 
glioma (LGG) (24), a spectrum of concerns including neurocogni-
tive and behavioral issues (25) and elevated psychological distress 
has been detected (13). PBT patients and caregivers are faced with 
a new reality of living over months to even years with the sequelae 
of brain tumor, due to the tumor and/or the effects of therapy (26). 
Furthermore, it is likely that the existing language barriers, the 
knowledge and ability to navigate through a complex healthcare 
system, cultural insensitivities, and a lack of patient-centered care 
(27, 28) affecting Culturally and Linguistically Diverse (CALD) 
cancer groups (29), are likely to be heightened in those patients 
and caregivers faced with the diagnosis of PBT (30).
The complexity and scope of needs experienced by brain tumor 
patients and their caregivers requires a coordinated response from 
healthcare services and providers. In Australia, a cancer care coor-
dinator is a position focused specifically on improving the patient 
journey. The care coordination role is designed to incorporate 
the critical functions of assessment and evaluation of clinical and 
supportive care needs and liaising with multidisciplinary teams 
(MDTs) to achieve timely and high quality care (31, 32).
This study aimed to assess the psychological distress of PBT 
patients and caregivers, as measured by the DT, in a clinic setting. 
The second aim was to ascertain if any high risk subgroups for 
psychological distress exist, for example, caregivers and those of 
non English speaking background (NESB).
Materials and Methods
Patient Population
The study population comprised PBT patients who were either 
newly diagnosed or who were experiencing first tumor recur-
rence. Likewise, as a separate group, caregivers of PBT patients 
with either malignant or benign tumors were assessed and under-
went DT screening from the period of May 2012 to August 2013. 
PBT categories included HGG, LGG, and benign brain tumors 
(BBTs), the most common of which included meningioma and 
pituitary tumors.
neuro-Oncology care coordinator role in 
south-West sydney
The NOCC in South Western Sydney Local Health District 
(LHD), serving a population of almost one million people, is a 
one full-time equivalent position that encompassed the care of all 
primary malignant and benign brain and spinal tumor patients 
diagnosed across three main teaching hospitals in the LHD. New 
cases and referrals were identified at MDT meetings held every 
2 weeks where all new and recurrent PBT cases were discussed 
with a consensus management plan recommended.
Psychological Distress screening
Study Procedures
Ethical approval to undertake the study was provided by South 
Western Sydney Area Health Service Human Research Ethics 
Committee. The NOCC conducted a screening assessment with 
each participant using the DT tool for psychological distress screen-
ing. DT screening was performed around the time of initial PBT 
diagnosis or at the time of first tumor recurrence. Likewise, DT 
screening was undertaken in caregivers of PBT patients either at 
initial diagnosis or first recurrence. DT screening for non English 
speaking patients was administered in the presence of a hospital-
based interpreter where available or alternatively an English 
speaking caregiver. The majority of DT screening assessments were 
performed with the NOCC face-to-face in an oncology outpatient 
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setting, or alternatively by phone, especially if patients were too 
unwell to attend clinic or had other logistical challenges.
Study Measures
The DT, a measure (8, 9, 33) validated in a variety of multisite 
cancer populations, was used to screen for psychological distress 
in the study cohort. Participants rated their level of distress in the 
past week on a scale of 1–10, with 0 = no distress, 5 = moderate 
distress, and 10 = extreme distress. Patients were then asked to 
indicate areas of problems listed under the following five main 
categories: physical, family, emotional, spiritual/religious, and 
practical. Patients and/or caregivers were subsequently referred 
onto relevant psycho-oncology services for further evaluation 
and intervention according to the problems identified.
The DT has traditionally been designed for and utilized in 
cancer patients only (33). However, it is widely acknowledged 
that there are multiple identified supportive care needs that exist 
in PBT caregivers (1, 3, 34). In addition, Zwahlen et al. reported 
a validation study supporting the use of the DT in screening the 
caregivers of cancer patients (35). Hence, where feasible in the 
current study, caregivers were also asked to complete the DT.
Patients and/or caregivers with a DT score ≥4 were referred 
by the NOCC to relevant psycho-oncology, Allied Health or 
community services, in keeping with documented and accepted 
clinical practice guidelines for psychological distress manage-
ment in oncology (9).
Selected patient demographic data including age and country 
of origin, English speaking versus non English speaking back-
ground, as well as clinical data including the PBT diagnosis, 
nature/timing of relevant treatments, and date of first (but not 
subsequent) tumor recurrence were collected.
It is widely acknowledged that there are many differing 
definitions for CALD groups. Although the Australian Bureau 
of Statistics (36) utilizes the category of “people who were born 
overseas,” for the purposes of the current study and also for the 
subsequent analysis, patients and caregivers were grouped into 
English speaking versus non English speaking groups rather than 
by country or regions of birth.
Data Management and statistical analyses
The oncology electronic medical record, Mosaiq®, was used as 
a platform to collect and extract relevant clinical information 
concerning all DT scores from patients and caregivers. Once 
extracted from Mosaiq®, descriptive statistics were generated for 
all variables.
Results have been ordered according to four independent 
participant groups: patients at diagnosis, patients at recurrence, 
caregivers at diagnosis, and caregivers at recurrence. Descriptive 
and frequency data were generated for DT scores. Next, for 
patients at diagnosis, an independent samples t-test tested for 
differences on DT scores between English speaking and non 
English speaking background participants. Then, a one-way 
ANOVA was conducted to test for statistical differences among 
the three tumor diagnosis groups (HGG versus BBT versus 
LGG). Scheffe post hoc comparisons were then conducted with 
an adjusted Bonferroni alpha of p < 0.016 (0.05/3). Due to insuf-
ficient sample size, similar tests were not conducted for any of 
the other three participant groups. Finally, scores on the DT 
were divided into two groups (<4 and ≥4) to identify caseness. 
Caseness can be defined in this context as any participant with 
psychological distress levels that were clinically significant, i.e., 
that require further assessment and/or intervention by psycho-
oncology services. Participants with DT scores ≥4 were classified 
as meeting caseness criteria (8).
results
sample
In total, 190 DT scores were collected. Of these, 25 patients and 11 
caregivers had completed the DT at more than one time point. In 
these cases, only the first instance of DT completion was retained 
for analysis. Data from a total of 154 DT scores remained. DT 
scores were collected from a varied neuro-oncology cohort that 
comprised HGG, LGG, and BBT patients, as categorized by the 
international WHO 2007 classification of brain tumors (37). 
All patients had a confirmed histopathological diagnosis. LGG 
patients were those with grade I or II glioma in contrast to those 
with BBT who were predominantly patients with meningioma 
and pituitary tumors.
Of the total number of DT assessments, 30.5% (47/154) were 
performed in NESB participants. Table  1 provides a summary 
of DT scores for PBT patients and caregivers, both at diagnosis 
TaBle 1 | summary of distress thermometer scores for primary brain 
tumor patients and caregivers, both at diagnosis and first tumor 
recurrence, according to tumor subgroups and english speaking 
background.
Patient caregiver
Diagnosis 
(n = 96)
recurrence 
(n = 12)
Diagnosis 
(n = 32)
recurrence 
(n = 14)
Total
Mean, SD 3.15 ± 2.20 5.42 ± 3.09 5.34 ± 1.89 7.64 ± 1.50
Range 0–8 1–10 2–8 5–10
hgg
n, % 39 (40.6) 8 (66.7) 22 (68.8) 11 (78.6)
Mean, SD 4.03 ± 2.36 5.13 ± 2.98 5.86 ± 1.81 7.64 ± 1.29
Range 0–8 1–9 3–8 5–9
lgg
n, % 8 (8.3) 1 (8.3) 4 (12.5) 1 (7.1)
Mean, SD 2.25 ± 1.28 2.00 4.25 ± 1.71 8.00
Range 0–4 – 2–6 –
BBT
n, % 49 (51.0) 3 (25.0) 6 (18.8) 2 (14.3)
Mean, SD 2.59 ± 1.97 7.33 ± 3.06 4.17 ± 1.72 7.50 ± 3.54
Range 0–8 4–10 2–7 5–10
esB
n, % 69 (71.9) 9 (75.0) 19 (59.4) 10 (71.4)
Mean, SD 3.03 ± 2.26 5.11 ± 2.67 5.53 ± 1.87 7.40 ± 1.43
Range 0–8 1–9 2–8 5–9
nesB
n, % 27 (28.1) 3 (25.0) 13 (40.6) 4 (28.6)
Mean, SD 3.44 ± 2.06 6.33 ± 4.73 5.08 ± 1.98 8.25 ± 1.71
Range 0–7 1–10 3–8 6–10
HGG, high-grade glioma; LGG, low-grade glioma; BBT, benign brain tumor; ESB, 
English speaking background; NESB, non English speaking background.
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and first tumor recurrence, and according to tumor subtypes and 
English speaking background.
Patients
A total of 96 DT scores were collected from patients at diagnosis, 
comprising 40.6% (39/96) with a diagnosis of HGG, 8.3% (8/96) 
with LGG, and 51.0 (49/96) with BBT. The highest mean DT 
scores were those with HGG tumors, followed by BBT and then 
LGG. For patients at diagnosis, 28.1% (27/96) were from NESB 
participants. DT scores were similar among NESB participants 
and those from an English speaking background (Table 1). Of all 
patients at the time of diagnosis, 37.5% (36/96) met criteria for 
caseness using the DT.
An independent samples t-test found no significant differences 
on DT scores between those from an English speaking and non 
English speaking background. A one-way ANOVA found statisti-
cally significant differences on DT scores among the three tumor 
groups, F(2, 93) = 5.882, p < 0.05. Scheffe post hoc tests showed 
that scores on the DT for the HGG diagnosis group were signifi-
cantly higher than those with a diagnosis of BBT (p < 0.016). No 
other significant differences were found.
Twelve patients at recurrence completed the DT. Of these, 66% 
(8/12) had a diagnosis of HGG, 8.3% (1/12) had LGG, and 25.0% 
(3/12) had BBT. Those with a diagnosis of BBT had the highest 
scores on the DT. Similar to patients at diagnosis, 25.0% (3/12) 
of patients at recurrence were from an NESB; however, scores on 
the DT were slightly elevated in comparison with those from an 
English speaking background. The majority of patients at recur-
rence met caseness criteria using the DT (75.0%, 9/12).
caregivers
A total of 32 caregivers at diagnosis completed the DT. These com-
prised 68.8% (22/32) supporting someone with HGG, 12.5% (4/32) 
with LGG, and 18.8% (6/32) with BBT. The highest DT scores were 
for those with a diagnosis of HGG. There was a high rate of caregiv-
ers at diagnosis from an NESB (40.6%, 13/32), and they had slightly 
higher DT scores than those from an English speaking background 
(Table 1). A large proportion of caregivers at the time of diagnosis 
met the caseness criteria for the DT (78.1%, 25/32).
Finally, DT scores were collected from 14 caregivers at recur-
rence. These were composed of 78.6% (11/14) supporting some-
one with HGG, 7.1% (1/14) LGG, and 14.3% (2/14) BBT. Scores 
on the DT were high among all tumor gradings for caregivers at 
recurrence, although the small group numbers did not allow for 
further comparison. Just under 30% of caregivers at recurrence 
were from an NESB (28.6%, 4/14) with similar mean scores on the 
DT (Table 1). All caregivers completing the DT at first recurrence 
had scores which met caseness criteria (100%, 14/14).
Discussion
Primary brain tumor patients have complex supportive care 
needs, and caregiver burden is high (2, 3, 21). At initial diagnosis, 
the poor prognosis associated with HGG, coupled with physi-
cal, neurocognitive, and behavioral sequelae associated with the 
disease and its associated therapies, can contribute to elevated 
psychological distress. Furthermore, due to the almost certain 
pattern of recurrence in HGG over time leading to high mortal-
ity rates, psychological distress levels can potentially increase 
throughout the disease journey.
In the current study, 37.5% of all newly diagnosed patients 
in the current population met caseness criteria for psychologi-
cal distress using the DT. This is comparable to other published 
literature where, using the same cutoff value, caseness ranged 
from 28% in newly diagnosed patients with glioblastoma with 
mean distress score of 2.15 (SD = 2.66) (11) to 52% in another 
PBT cohort at diagnosis (10). Similarly, Goebel et al. (38) assessed 
159 patients with varied types of malignant and benign PBT, the 
majority of whom were diagnosed within the last 3 months. Using 
a higher DT cutoff of ≥6, 48.4% of patients were experiencing 
distress with 6.9 sources of cancer-related distress. DT scores 
were significantly associated with depression and anxiety as well 
as the reported number of concerns.
The findings of the current study confirm that levels of psycho-
logical distress as measured by the DT are high in patients with 
PBT. In patients overall, the DT score a mean of 3.15 (SD, 2.20) 
at initial diagnosis and a mean of 6.49 (SD, 2.61) at first tumor 
recurrence. In comparison, distress was higher in caregivers 
overall, with mean DT score at diagnosis of 5.34 (SD, 1.89) and 
8.2 (SD, 1.47) in caregivers assessed at first recurrence.
The results presented here also highlight that psychological 
distress was particularly elevated in patients with HGG compared 
with low grade and benign tumor groups overall. Such a finding 
is intuitive, given the propensity for relatively rapid tumor recur-
rence and progressive functional decline, and is supported by 
other studies with similar conclusions (10, 11). Given the cross-
sectional design of the current study and the small numbers of 
patient–caregivers dyads who were assessed with the DT at both 
diagnosis and again at first recurrence, it is not possible to make 
any conclusions about the longitudinal patterns of psychological 
distress.
There are a number of published studies that have attempted 
to describe the longitudinal patterns of psychological distress 
and/or mood disorder. Rooney et  al. (12) sampled newly 
diagnosed glioma patients at three time points: T1 (n =  154 
patients) shortly after starting chemo/radiotherapy, T2 (n = 103 
patients) 3 months later, and T3 (n = 83 patients) 6 months later. 
Significant distress was present in 36.4% at T1, 35.9% at T2, and 
33.7% at T3. Longitudinally, subjects with high distress at T1 
(median DT score =  8) remained highly distressed at follow-
up (T2 median =  8, T3 median =  7). Younger age, functional 
impairment, and concurrent major depressive disorder were 
independently associated with high distress with emotional dif-
ficulties among the most common causes of distress at all three 
time points. In a study by Keir et al. (6), 83 glioblastoma patients 
were arbitrarily divided into those who had survived less than 
or greater than 18 months. Of the LTS, 59% met DT ≥4 cutoff 
for distress compared with 49% of those diagnosed <18 months 
ago. This study concluded that regardless of LTS status, distress 
continued to be a part of the disease trajectory for many glio-
blastoma patients. This study also concluded that understanding 
the sources of distress in PBT patients would aid clinical teams 
in better developing targeted interventions to help address and 
reduce psychological distress (6).
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The longitudinal time course of psychological distress and 
its relationship to other mood-related symptoms remains to be 
clarified. Kangas et al. (13) studied the effects of radiotherapy on 
the psychological [i.e., posttraumatic stress symptoms (PTSS)] 
and cognitive functioning of adults with PBT, who were assessed 
at two time points  –  pre-radiotherapy (T1) and 3.5  months 
post-radiotherapy (T2). Minimal differences in functioning were 
found between patients according to BT type (benign n =  45 
versus malignant n  =  25). Seventeen percent of the cohort 
reported clinically elevated PTSS at T1, which reduced to 13% at 
T2. Younger age (<65 years), reduced quality of life (QoL), and 
elevated anger symptoms at T1 predicted PTSS at T2, while hav-
ing a benign BT, low PTSS, and depressive symptoms at T1 were 
predictive of improved QoL at T2. Lamperti et al. (14) analyzed 
81 patients with recurrent central nervous system tumors and 
found that rather surprisingly the emotional well-being mean 
score was significantly higher in the recurrence sample than in 
patients with brain tumors at first diagnosis. Anxiety did not 
seem to be influenced by a relapse diagnosis; instead, depression 
was higher and differed significantly from normative data. Their 
data suggested that some patients retained highly preserved 
coping strategies for managing emotional distress despite intact 
judgment and disease awareness.
To our knowledge, the present study has reported DT findings in 
one of the largest cohorts of non English speaking neuro-oncology 
populations. Despite this, the current study did not find signifi-
cant differences in DT scores between non English  speaking and 
English speaking groups. It is appreciated that cultural diversity is 
a much more holistic concept than spoken language alone. Kayser 
et al. (39) undertook a systematic review of 148 psycho-oncology 
studies and reported that screening measures of distress had com-
parable reliability, sensitivity, and specificity for Caucasian, Latino, 
and Asian samples, but it was unclear if equivalent psychometrics 
could be found among minority ethnic groups (e.g., African 
American) and immigrants within countries. Donovan et al. (40) 
reported on 18 non English translations of the DT and found that 
although cutoff scores varied by language, country, clinical setting, 
and sample characteristics, a DT score of 4 maximized sensitivity 
and specificity. Ongoing research by McGrane et al. (41) in CALD 
populations has addressed the utility of a culturally competent 
multilingual unmet needs survey in cancer patients.
Findings from the current study substantiate existing studies 
reporting that PBT caregivers experience significantly elevated 
psychological distress (1, 16, 22, 42–44). In the current study, of 
the 32 caregivers screened at the time of initial PBT diagnosis, 
78% met caseness criteria with DT ≥4. Furthermore, 100% (all 
14 caregivers) met distress criterion at the time of first tumor 
recurrence.
Petruzzi et al. (45) assessed patients with the Hospital Anxiety 
and Depression Scale (HADS), Functional Assessment of Cancer 
Therapy – Brain (FACT-Br) and caregivers with HADS, Caregiver 
Reaction Assessment Scale (CRA), and the 36-Item Short-Form 
Health Survey (SF-36). They reported that most caregivers expe-
rienced more depressive and anxiety symptoms compared with 
patients. In addition, the clinical and psychological features of 
patients did not correlate with psychological patterns of their own 
caregivers. In another study by Brown et al. (46) addressing the 
serial QoL measurements of 197 PBT patients and their caregivers, 
there was better agreement between patient and caregiver scores 
when the QOL scores were higher. Such studies underscore the 
complex interrelationship between the emotional state of the PBT 
patient and their caregiver over time.
It is therefore relevant to consider potential reasons why car-
egivers might experience higher levels of psychological distress 
than patients at the time of diagnosis and at recurrence. Although 
clinical disclosure of tumor recurrence would always ideally occur 
in the presence of both the patient and their caregiver/s, it is pos-
sible that due to altered recall, insight, or changes in memory and 
other cognitive processes, the patient is not able to retain all the 
information and management plans disclosed. In practical terms, 
it is also not uncommon for caregivers to intentionally seek out 
additional prognostic information from the treating healthcare 
team in another confidential forum. Caregivers sometimes prefer 
to shield the patient from exchanges where poor prognostic news 
is relayed. Another possible contributing factor to distress is that 
caregivers may be faced with the additional decisions regarding 
palliative care options, increasing symptom (physical, cognitive) 
burden and financial stress.
implications of study Findings
The results presented here have a number of implications for 
clinical care of adults with PBT. Firstly, given the elevated levels 
of psychological distress in this cohort of patients and caregiv-
ers, it is imperative that they undergo systematic and routine 
psychological distress screening. Distress screening is considered 
a fundamental component of a holistic model for psychological 
services, which should contribute to the development of a treat-
ment plan and appropriate and timely referrals and thus effective 
interventions (47).
Due to the projected trajectory of tumor recurrence in 
HGG patients, such screening, triage, and referral systems 
need to incorporate repeat screening over time for patients 
and caregivers at relevant points in the illness trajectory (i.e., 
diagnosis, recurrence, and the terminal phase). A population of 
PBT patients and their caregivers would be a potentially ideal 
group in which to adopt a tiered approach to psychological 
interventions, as outlined by Hutchison et al. (48), whereby the 
level of distress and expressed need is matched to an appropriate 
level of care. Such levels of care range from 1 (universal) for those 
with minimal or mild distress to supportive (2) and (3) extended 
care (mild to moderate distress), then increasing to (4) special-
ized and (5) acute care for those affected by moderate to severe 
psychological distress.
This then leads to the discussion of the workforce that could 
provide such care for this particular group of patients and car-
egivers. In Australia and New Zealand, the majority of cancer 
care coordinators come from a specialist nurse or allied health 
professional background (49). Given the rarity of primary 
malignant brain tumors, with just over 1,700 new projected 
cases of brain cancer diagnosed in 2014 in Australia, and an 
incidence of 7.2 per 100,000 (50), a neuro-oncology-specific 
care coordinator is understandably a very uncommon role and 
recurrent funding remains an ongoing challenge. The title and 
the constituents of the role varies considerably, as described in 
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Europe (51–53), North America (26), and other regions such 
as Israel (54). Some of the roles focus on cancer treatments 
(such as chemotherapy management) versus a more holistic 
model of supportive care throughout the entire care trajectory.
A neuro-oncology-specific care coordinator is well posi-
tioned to facilitate symptom and needs assessment, psycho-
logical support and referrals or intervention throughout the 
care continuum, and particularly so at predictable time points 
along the care journey where patients and caregivers are likely to 
experience higher distress levels. Due to the complexity, this role 
necessitates an experienced health practitioner familiar with the 
symptomatology, needs, and journey of a brain tumor patient. 
It is important that patient and caregiver needs are anticipated, 
proactively screened for and detected early, to ensure that timely 
intervention can occur. Furthermore, as many Australian cancer 
services will not routinely collect nor screen cases such as benign 
brain tumor patients (as their data are not typically collected by 
cancer registries), a neuro-oncology service should ideally have 
mechanisms to support this specific subgroup of PBT patients 
and their caregivers with a longer survivorship trajectory.
As most cancer services will not have the benefit of a dedi-
cated, neuro-oncology-specific care coordinator, alternate mod-
els of service delivery will rely more fully on psycho-oncology 
staff and/or a programmatic system-wide approach for distress 
screening (55) and overall coordination of care by all members of 
the healthcare team. Given the rarity of PBT overall, there have 
been efforts to expand the knowledge and skillset and educate and 
train healthcare professionals regarding brain tumors as exempli-
fied by the Australian initiative which included a specific online 
module about brain cancer (56). Tailored information provision 
and education is a vital component of the care coordination role 
(57, 58). In the setting of uncommon tumors, although there are 
now adequate English language resources covering most aspects 
of cancer care, there remains a paucity of translated high quality 
material in non English languages. The costs of translating exist-
ing resources remain another practical barrier.
There were several limitations of the current study. Firstly, 
DT data beyond the first tumor recurrence were not captured, 
and thus it is possible that patients and/or caregivers could have 
experienced even higher psychological distress levels during the 
terminal phase of care. Secondly, not all NESB participants and 
not all caregivers were able to be assessed – hence, it is unclear 
to what extent the caregiver sample and NESB sample were 
representative of the broader population. It is also acknowledged 
that the caregiver group was relatively small and thus results 
should ideally be verified in a larger sample. In addition, a 
notable proportion of benign PBT caregivers were not accessible 
for assessment due to the fact that benign PBT patients often 
attended clinical consultations alone.
Finally, it was not possible to compare the level of psychologi-
cal distress and caseness between the four subgroups due to the 
differing composition of these groups. Rather, the current study 
was largely descriptive in summarizing DT data for four different 
groups in a clinical setting.
Finally, future research directions could include an investiga-
tion of the impact of screening for psychological distress at vari-
ous time points upon the workflow of a cancer care coordinator. 
It would also be interesting to compare distress levels in patients 
and caregivers during phases in which there is evidence of disease 
stability, to better understand the support that is needed.
conclusion
This study demonstrates the prevalence of elevated psychological 
distress in a neuro-oncology population of patients at diagnosis 
and at first recurrence and also in caregivers. The groups exhibiting 
the highest distress levels included patients with HGG, patients 
with disease recurrence, and caregivers. It is thus imperative that 
both patients and caregivers have access to timely, systematic care 
coordination and needs assessment as well as a skilled and knowl-
edgeable healthcare team who can provide effective intervention 
and support across the care trajectory.
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